Spectral Medical Inc banner

Spectral Medical Inc
OTC:EDTXF

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
OTC:EDTXF
Watchlist
Price: 1.028 USD 0.78% Market Closed
Market Cap: $287.2m

Wall St Price Targets

EDTXF Price Targets Summary
Spectral Medical Inc

Wall Street analysts forecast EDTXF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EDTXF is 2.31 USD with a low forecast of 2.033 USD and a high forecast of 2.642 USD.

Lowest Forecast
Price Target
2.033 USD
98% Upside
Average Forecast
Price Target
2.31 USD
125% Upside
Highest Forecast
Price Target
2.642 USD
157% Upside
Spectral Medical Inc Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
29% Upside
ZNTL
Zentalis Pharmaceuticals Inc
54% Upside
PGEN
Precigen Inc
131% Upside
MRVL
Marvell Technology Group Ltd
-25% Downside
PTGX
Protagonist Therapeutics Inc
13% Upside

Revenue
Forecast

0% / Year
Past Growth
91% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
0% / Year
Past Growth
91% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 91%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EDTXF's stock price target?
Price Target
2.31 USD

According to Wall Street analysts, the average 1-year price target for EDTXF is 2.31 USD with a low forecast of 2.033 USD and a high forecast of 2.642 USD.

What is the Revenue forecast for Spectral Medical Inc?
Projected CAGR
91%

Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 91%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett